ESMO Therapeutic Landscapes Webinar Series is designed for oncology professionals seeking a deeper understanding of today’s rapidly evolving therapeutic environment

With a broad and inclusive focus, this series explores the latest scientific advances and clinical practices in oncology. From molecular insights to novel systemic therapies, each session highlights the state of the art care pathways, including recent breakthroughs, across cancer types.

Image 5 - Digital education

ABOUT THE WEBINAR SERIES

ESMO Guidelines Webinar series_ Cover-1-1

Explores the latest scientific advances and clinical practices in oncology

ESMO Guidelines Webinar series_ Cover-1-1

The faculty consists of three speakers, identified as leading experts in the specific area

ESMO Guidelines Webinar series_ Cover-1-1

Each 60 minute webinar includes interactive, live presentations, discussion and Q&A

ESMO Guidelines Webinar series_ Cover-1-1

Webinars take place on a Wednesday through the ESMO On Air initiative

This webinar series is multi-sponsored per series

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 1: TOXICITY OF CELLULAR THERAPIES - CAR T-CELLS

21 JANUARY 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 2: TOXICITY OF MULTISPECIFIC ANTIBODIES AND IMMUNE CELL ENGAGERS

18 FEBRUARY 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 3: TUMOUR AGNOSTICS

15 APRIL 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 1:

NEXT GENERATION ANTIBODY-DRUG CONJUGATES: TECHNOLOGICAL ADVANCES, DRUG DEVELOPMENT AND COMBINATION STRATEGIES

27 MAY 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 2:

CLINICAL DEVELOPMENT AND THERAPEUTIC APPLICATIONS OF ANTIBODY DRUG CONJUGATES

8 JULY 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

ESMO Guidelines Webinar series_ Cover-2-1

WEBINAR 3:

OPTIMISING ANTIBODY-DRUG CONJUGATE SAFETY: MECHANISMS, MONITORING AND MANAGEMENT OF TOXICITIES

27 MAY 2026

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

3 Cristian Massacesi New York

First and Last Name

Italy (Co-Chair)

EXTENSIVE COMPANY/LOGO RECOGNITION

WEBINAR HOSTED ON-DEMAND ON ONCOLOGYPRO FOR 2 YEARS

FULL OUTCOMES REPORT INCLUDING LIVE AND ON-DEMAND METRICS

LOREM IPSUM DOLOR SIT AMET LOREM IPSUM

ESMO THERAPEUTIC LANDSCAPES WEBINARS 2025 - STATISTICS

PARTICIPANTS

594

Countries & Territories

57

Oncology Clinicians

58.7%

Abstracts presented

121

Programme Speakers

66